Projected savings from biosimilars from 2021 to 2025 were $38.4 billion vs conditions as of quarter 4 of 2020 and were driven by new biosimilar entry. Savings were $124.5 billion under an upper-bound scenario.
Amber Jessup, PhD
Advertisement
Articles by Amber Jessup, PhD
Advertisement
Latest Updated Articles
- Projected US Savings From Biosimilars, 2021-2025
January 3rd 2022
Advertisement
Advertisement
Trending on AJMC
1
CDC Officially Ends Hantavirus Response as Outbreak Risk Recedes
2
FDA Approves Palbociclib for HR+, HER2+ Breast Cancer Maintenance
3
Respiratory Biologics Linked to Reduced Asthma Exacerbations Across Patient Groups
4
Zanubrutinib Tops Rivals in Real-World CLL Survival Study
5